204 related articles for article (PubMed ID: 27322553)
1. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
[TBL] [Abstract][Full Text] [Related]
2. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
3. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
[TBL] [Abstract][Full Text] [Related]
5. Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.
D'Amico L; Patanè S; Grange C; Bussolati B; Isella C; Fontani L; Godio L; Cilli M; D'Amelio P; Isaia G; Medico E; Ferracini R; Roato I
Br J Cancer; 2013 Jun; 108(12):2525-36. PubMed ID: 23801032
[TBL] [Abstract][Full Text] [Related]
6. Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.
Mukai S; Yorita K; Kawagoe Y; Katayama Y; Nakahara K; Kamibeppu T; Sugie S; Tukino H; Kamoto T; Kataoka H
Hum Cell; 2015 Jan; 28(1):44-50. PubMed ID: 25186085
[TBL] [Abstract][Full Text] [Related]
7. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
8. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction.
Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L
Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown.
Previdi S; Abbadessa G; Dalò F; France DS; Broggini M
Mol Cancer Ther; 2012 Jan; 11(1):214-23. PubMed ID: 22027690
[TBL] [Abstract][Full Text] [Related]
10. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A
Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
12. c-Met in pancreatic cancer stem cells: therapeutic implications.
Herreros-Villanueva M; Zubia-Olascoaga A; Bujanda L
World J Gastroenterol; 2012 Oct; 18(38):5321-3. PubMed ID: 23082047
[TBL] [Abstract][Full Text] [Related]
13. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
Sun S; Wang Z
Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.
Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL
Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343
[TBL] [Abstract][Full Text] [Related]
17. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
18. c-Met is a marker of pancreatic cancer stem cells and therapeutic target.
Li C; Wu JJ; Hynes M; Dosch J; Sarkar B; Welling TH; Pasca di Magliano M; Simeone DM
Gastroenterology; 2011 Dec; 141(6):2218-2227.e5. PubMed ID: 21864475
[TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a new cell line from a renal carcinoma bone metastasis.
Avnet S; Cenni E; Granchi D; Perut F; Amato I; Battistelli L; Brandi ML; Giunti A; Baldini N
Anticancer Res; 2004; 24(3a):1705-11. PubMed ID: 15274344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]